Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

Clinical trial NCT01482767 · COMPLETED

Trial details

NCT number: NCT01482767
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Infections Hepatitis C

Start date: 2012-04-01
Primary completion: 2015-04-01
Enrollment: 262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.